Deal · Agreement signed
Laboratory Corporation of America and Assets sold by Myriad Genetics Inc
First filed 20 Oct 2026, 1 filing.
The deal
- Buyer
- Laboratory Corporation of America
- Target
- Assets sold by Myriad Genetics Inc
- Seller
- Myriad Genetics Inc
- Status
- Agreement signed
- Region
- US
On October 19, 2026, Myriad Genetics, Inc., a Delaware corporation (the "Company"), and Laboratory Corporation of America, a Delaware corporation ("Buyer"), entered into an Asset Purchase Agreement (the "Purchase Agreement").
Source: The filing (SEC Form 8-K)
With a free account
A free account opens 10 full pages a month and lets you follow this page: alerts on the next filing, buyer lists, exports.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.